摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-Amino-6-fluorophenyl)propan-1-one | 869937-09-7

中文名称
——
中文别名
——
英文名称
1-(2-Amino-6-fluorophenyl)propan-1-one
英文别名
——
1-(2-Amino-6-fluorophenyl)propan-1-one化学式
CAS
869937-09-7
化学式
C9H10FNO
mdl
——
分子量
167.183
InChiKey
OXVBDGVQQSYSKI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    43.1
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Novel Lipopeptides as Antibacterial Agents
    申请人:Hill Jason
    公开号:US20090011977A1
    公开(公告)日:2009-01-08
    The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.
    本发明涉及新型脂肽化合物。本发明还涉及这些化合物的药物组合物以及将这些化合物用作抗菌化合物的方法。本发明还涉及生产这些新型脂肽化合物的方法以及用于生产这些化合物的中间体。
  • NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
    申请人:Yoshida Tomohiro
    公开号:US20100228026A1
    公开(公告)日:2010-09-09
    The invention provides a sulfonyl malonamide derivative, or a pharmacologically acceptable salt thereof or a solvate thereof, that has therapeutic and/or preventive effect(s) on various diseases due to its agonist action at AT 2 receptor, and is useful as a pharmaceutical agent for the treatment and/or prevention of diseases involving the renin-angiotensin-aldosterone system (RAAS).
    该发明提供了一种磺酰基马隆酰胺衍生物,或其药理学上可接受的盐或溶剂,由于其在AT2受体上的激动剂作用,对各种疾病具有治疗和/或预防作用,并且作为用于治疗和/或预防涉及肾素-血管紧张素-醛固酮系统(RAAS)疾病的药物剂形具有用处。
  • SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF
    申请人:Memorial Sloan-Kettering Cancer Center
    公开号:US20220162209A1
    公开(公告)日:2022-05-26
    Provided herein are compounds of Formula (I), and pharmaceutically acceptable salts or tautomers thereof. Also provided are pharmaceutical compositions, kits, and methods involving the inventive compounds for the treatment and/or prevention of an infectious disease (e.g., bacterial infection (e.g., Mycobacterium infection (e.g., tuberculosis)). (I)
  • US7241769B2
    申请人:——
    公开号:US7241769B2
    公开(公告)日:2007-07-10
查看更多